This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Morphosys Ag. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Daniela Della Ducata: Innovator in Rheumatoid Arthritis Treatment
Introduction
Daniela Della Ducata is a prominent inventor based in Planegg, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of rheumatoid arthritis. Her innovative work has led to the development of a unique therapeutic approach that utilizes anti-GM-CSF antibodies.
Latest Patents
Della Ducata holds a patent for a treatment specifically designed for rheumatoid arthritis. The patent details the use of anti-GM-CSF antibodies, particularly MOR103, which are administered to patients at dosages that are beneficial in a clinical setting. This invention represents a significant advancement in the management of this chronic condition.
Career Highlights
Throughout her career, Daniela has been associated with Morphosys AG, a leading biotechnology company. Her work at Morphosys has allowed her to focus on innovative treatments that address unmet medical needs. With her expertise, she has contributed to the advancement of therapeutic options for patients suffering from rheumatoid arthritis.
Collaborations
Della Ducata has collaborated with notable colleagues, including Stefan Hartle and Stephane Leclair. These partnerships have fostered a collaborative environment that enhances the research and development of new treatments.
Conclusion
Daniela Della Ducata is a trailblazer in the field of rheumatoid arthritis treatment, with her innovative patent showcasing her commitment to improving patient care. Her work continues to inspire advancements in medical research and therapeutic development.